| No. | Drug Name | Active Ingredient | Date | What It’s Used For |
| 23. | Orbactiv | oritavancin | 8/6/2014 | To treat adults with skin infections
" I6 c$ W0 h# }) L. i: q* x Press Release |
| 22. | | empagliflozin | 8/1/2104 | To improve gylcemic control in adults with type 2 diabetes- [' |) }3 Q2 _ y5 o6 f
Press Release |
| 21. | | olodaterol | 7/31/2014 | To treat chronic obstructive pulmonary disease
$ B+ G, ^9 N J# l4 ~ Press Release |
| 20. : Y: _; [2 I* y1 E3 N) o/ ^
# p! Q5 i+ ?: Y2 V1 Z) o
| | idelalisib | 7/23/2014 | To treat patients with trhee types of blood cancers9 I& N+ u$ l& ^) ]1 c
Press Release |
| 19. | Kerydin3 E; F5 ~$ ~, I, I N# w) s
% s1 h/ A( V* v! u3 H1 ]/ p2 k | tavaborole | 7/7/2014 | For the topical treatment of onychomycosis of the toenails 1 u5 c4 `7 a- L. W1 T: V
(No Press Release) |
| 18. | | belinostat | 7/3/2014 | To treat patients with peripheral T-cell lymphoma (PTCL) ! z( `3 A: m- ^
Press Release |
| 17. | | tedizolid phosphate | 6/20/2014 | To treat adults with skin infections8 Q7 L! t0 X) ?, j! Q* U0 z3 P/ A
Press Release |
| 16. | Jublia$ n+ e1 G& b7 |( s
$ a8 I' ~: j+ P: c7 o% n) w
| efinaconazole | 6/6/2014 | Treat mild to moderate onychomycosis (fungal infection)
" H' v5 N0 `. L, p4 T No Press Release |
| 15. | Dalvance
$ Z; O2 T2 q* f# L
1 Z1 T4 @/ j2 Z j; U | dalbavancin | 5/23/2014 | To treat adults with skin infections" }. u7 }) ]8 Z) T! B8 U
Press Release |
| 14. | Entyvio
* i6 G0 O5 J# x* S, G
! s! Z. b# W: c+ [ | vedolizumab | 5/20/2014 | To treat adult patients with moderate to severe ulcerative colitis and adult patients with moderate to severe Crohn‘s disease
, X$ I) K" A' o; j) z! s4 [ Press Release |
| 13. | Zontivity
! m. P- U2 k w! k; ]0 j4 u5 [
' `8 d# t$ g% u0 ^, U | vorapaxar | 5/8/2014 | To reduce the risk of heart attacks and stroke in high-risk patients
0 i3 \, T4 D/ \! b Press Release |
| 12. | | ceritinib | 4/29/2014 | To treat patients with a certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC)' p3 Y N( @" x' R: m9 J5 B
Press Release |
| 11. | | siltuximab | 4/23/2014 | To treat patients with multicentric Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the lymph nodes)
! f+ Y1 ?/ O: Y" ]+ I: a Press Release |
| 10. | | ramucirumab | 4/21/2014 | To treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma
- j7 D' t/ q& G0 q v/ k5 z Press Release |
| 9. | | albiglutide | 4/15/2014 | To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes H( d! M8 O7 y( M+ [
Press Release |
| 8. | | apremilast | 3/21/2014 | To treat adults with active psoriatic arthritis (PsA)
. y: Z! ~* D; C/ T' R3 s6 s5 n Press Release |
| 7. | | miltefosine | 3/19/2014 | To treat a tropical disease called leishmaniasis
; E! ~) F* u m- B Press Release |
| 6. | | florbetaben F 18 injection | 3/19/2014 | For Positron EmissionTomography (PET) imaging of the brain |
| 5. | | metreleptin for injection | 2/24/2014 | To treat the complications of leptin deficiency
$ L; L2 U: |1 v$ f Press Release |
| 4. | | droxidopa | 2/18/2014 | To treat neurogenic orthostatic hypotension (NOH)5 f, O3 q6 |+ X8 C4 d
Press Release |
| 3. | | elosulfase alfa | 2/14/2014 | Treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome)2 d! ?: u: d$ J0 d) S5 K
Press Release |
| 2. | | tasimelteon | 1/31/2014 | To treat non-24- hour sleep-wake disorder (“non-24”) in totally blind individuals. Non-24 is a chronic circadian rhythm (body clock) disorder in the blind that causes problems with the timing of sleep.Press Release |
| 1. | | dapaglifozin | 1/8/2014 | To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes; y7 y+ {% j" z
Press Release |
|手机版|药群论坛
( 蜀ICP备15007902号 )
收藏
支持
反对